% | $
Quotes you view appear here for quick access.

AstraZeneca PLC Message Board

  • telxontrader telxontrader Mar 29, 2011 11:29 AM Flag

    O.T. "MNKD" - Potential Partnership


    AstraZeneca recent purchase of Rigel's R788 indicates that the company is actively seeking acquisitions/partnerships.

    The company has been mentioned in the past as a potential Mannkind partner for Afrezza. Mannkind's management has stated that they are currently in partnership talks.

    Mannkind's depressed share price offers considerable upside on a partnership announcement considering that over 30% of the float is shorted here.

    Due diligence but consider buying a few shares.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Mannkind's share price has started a definite uptrend.

      The C.E.O., billionaire Al Mann, recently stated that Mannkind was in talks with multiple potential partners.

      A recent rumor from stated that Lilly was readying a $12.50/share offer for Mannkind.

      Big pharma is faced with losing over $100 billion in revenues over the next three years with drugs going "off-patent". Mannkind is one of the few companies with a potential blockbuster drug in late stage development that is a realistic partner or buyout target for a major drug company.

      With almost 25,000,000 shares short (about 40% of the float) news of a partnership could take the share price to the $15.00 range.

      Due diligence but do check it out before it gaps higher.

27.86-1.43(-4.88%)Jun 24 4:03 PMEDT